HER2 Negative Breast Carcinoma trials recruiting in California

All HER2 Negative Breast Carcinoma trials nationally

Cities in California

Recruiting trials in California

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Auburn, Bakersfield, Berkeley, Beverly Hills
• Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
  NCT06042569 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · California: Duarte
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
  NCT07085767 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Beverly Hills, La Jolla, Los Alamitos, San Francisco
• Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
  NCT06774027 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
  NCT07391774 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Auburn, Berkeley, Beverly Hills, Irvine